Dr. Antonella Conforti represents EVVIVAX at the fifth UK & International Veterinary Vaccinology Network Conference. Topics will range from vaccine commercialisation to antigen discovery, with scientists from all over the world delivering speeches about vaccine research.
EVVIVAX has expertise in genetic cancer vaccines for pets and is committed to developing new therapeutic strategies with strong translational potential. We cannot miss this appointment, where innovative approaches and incoming challenges in veterinary vaccinology will be addressed, with the awareness that fighting animal diseases will also affect men’s health.
This year, we are plenty of ideas to further expand our research activities: we are excited to share our knowledge and look forward opportunities to network and form new collaborations in London!
ABOUT THE VETERINARY VACCINOLOGY NETWORK
The Veterinary Vaccinology Network is a multidisciplinary community who aims to address the unmet needs in veterinary vaccinology in the fight against animal diseases and consequently those that have the potential to spread to humans. The network aims to enhance collaborations between scientific researchers, industry, policy makers and regulators to design, develop and deliver safe and effective next-generation vaccines against new and (re)-emerging diseases.